✦ LIBER ✦

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil

✍ Scribed by Marco Colleoni; Karen N Price; Monica Castiglione-Gertsch; Richard D Gelber; Alan S Coates; Aron Goldirsch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin and Cyclophosphamide, Methotr

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAP

✍ Howell, A.; George, W.D.; Crowther, D.; Rubens, R.D.; Bulbrook, R.D.; Bush, H.; 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 568 KB

Adjuvant chemotherapy for early breast c

✍ Robin STUART-HARRIS; Helen ODELL; Elizabeth STURGISS 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Tolerability and safety of classic cyclo

✍ Keiichiro Tada; Yoshinori Ito; Shunji Takahashi; Kohtaro lijima; Yumi Miyagi; Se 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 444 KB

On the safety of perioperative adjuvant

📂 Article 📅 1988 🏛 Elsevier Science ⚖ 409 KB

Cost-effectiveness of adjuvant chemother

✍ A. Messori; P. Becagli; S. Trippoli; E. Tendi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 83 KB